Elke Schaeffeler Selected Research

Organic Cation Transporter 1

1/2020	Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.
2/2014	Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elke Schaeffeler Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 08/2009
11	Crohn Disease (Crohn's Disease) 03/2013 - 10/2005
10	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 10/2015
9	Drug-Related Side Effects and Adverse Reactions 01/2021 - 12/2003
7	Coronary Artery Disease (Coronary Atherosclerosis) 05/2022 - 09/2008
6	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2011
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016 - 01/2007
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
5	Acute Coronary Syndrome 11/2020 - 09/2008
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 03/2005
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 12/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2016
3	Fibrosis (Cirrhosis) 01/2020 - 01/2016
3	Thrombosis (Thrombus) 01/2017 - 12/2014
2	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 10/2020
2	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2014
2	Solitary Kidney 01/2019 - 01/2018
2	Cardiomyopathies (Cardiomyopathy) 01/2018 - 01/2016
2	Ischemic Stroke 01/2018 - 01/2016
2	Muscular Dystrophies (Muscular Dystrophy) 01/2018 - 01/2016
2	Leukemia 01/2017 - 04/2013
2	Atherosclerosis 01/2017 - 10/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2015 - 09/2008
2	Diarrhea 05/2008 - 05/2008
2	Inflammation (Inflammations) 09/2006 - 12/2005
2	Ulcerative Colitis 12/2005 - 01/2003
2	Colitis 10/2005 - 01/2003
2	Hypertension (High Blood Pressure) 01/2005 - 06/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2022
1	Memory Disorders (Memory Loss) 02/2021
1	Infections 01/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Myocardial Infarction 11/2020
1	Stroke (Strokes) 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 10/2020

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 01/2022 - 10/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
8	Azathioprine (Imuran)FDA LinkGeneric 04/2013 - 10/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 01/2020 - 12/2011
5	2-mercaptopurineIBA 10/2016 - 01/2007
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021 - 03/2012
4	Clopidogrel (Plavix)FDA Link 01/2020 - 09/2008
4	Cytochrome P-450 CYP3AIBA 01/2019 - 01/2005
4	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 04/2013 - 03/2005
3	EnzymesIBA 01/2022 - 03/2005
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 09/2013
3	Thioguanine (Tioguanine)FDA Link 01/2021 - 10/2005
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 01/2005
3	Tamoxifen FDA LinkGeneric 01/2020 - 01/2017
3	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2017 - 02/2014
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2014 - 10/2002
3	CationsIBA 12/2014 - 10/2009
3	Mesalamine (Mesalazine)FDA LinkGeneric 03/2013 - 02/2007
3	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 08/2009 - 03/2005
2	LipidsIBA 10/2020 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2014
2	Peptides (Polypeptides)IBA 01/2020 - 01/2011
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2017
2	Organic Cation Transporter 1IBA 01/2020 - 02/2014
2	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2018
2	4-hydroxy-N-desmethyltamoxifenIBA 01/2019 - 01/2017
2	Monocarboxylic Acid TransportersIBA 12/2018 - 09/2013
2	GadoliniumIBA 01/2018 - 01/2016
2	Metformin (Glucophage)FDA LinkGeneric 11/2015 - 02/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014 - 01/2013
2	alpha-DefensinsIBA 01/2009 - 12/2005
2	DefensinsIBA 01/2009 - 09/2006
2	Cytochrome P-450 CYP2C19IBA 09/2008 - 12/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2008 - 01/2003
2	NucleotidesIBA 05/2008 - 02/2007
2	Chloride Channels (Chloride Channel)IBA 04/2006 - 06/2004
2	SaltsIBA 04/2006 - 06/2004
1	Junctional Adhesion Molecule AIBA 05/2022
1	ThioredoxinsIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	N-nitroso-N-methyltyramine (NNMT)IBA 01/2022
1	Nicotinamide N-MethyltransferaseIBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022
1	Amyloid beta-PeptidesIBA 02/2021
1	Cholinergic Agents (Cholinergics)IBA 02/2021
1	Angiotensin Receptor AntagonistsIBA 02/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Valganciclovir FDA Link 01/2021
1	ParaffinIBA 10/2020
1	Formaldehyde (Formol)FDA Link 10/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	mesedinIBA 01/2020
1	Cyclophilin AIBA 01/2020

Therapy/Procedure

14	Therapeutics 01/2021 - 05/2008
3	Drug Therapy (Chemotherapy) 01/2021 - 03/2005
3	Aftercare (After-Treatment) 08/2009 - 03/2005
2	Precision Medicine 12/2021 - 01/2021
2	Percutaneous Coronary Intervention 11/2020 - 01/2018
2	Transplantation 10/2020 - 01/2019
1	Organ Transplantation 01/2021
1	Intranasal Administration 10/2020
1	Drug Tapering 01/2020